(Q35956167)

English

Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

congenital disorder

0 references

1 reference

based on heuristic

inferred from title

congenital heart disease

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

author name string

M D'Alto

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

C D Vizza

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

E Romeo

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Badagliacca

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

G Santoro

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Poscia

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

B Sarubbi

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Mancone

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

P Argiento

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

F Ferrante

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M G Russo

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

F Fedele

12

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

R Calabrò

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

29 November 2006

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

93

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

621-625

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

The endothelin system in pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

The incidence and life expectation of children with congenital heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Eisenmenger's syndrome: current management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Eisenmenger syndrome. Factors relating to deterioration and death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Circulating endothelin in children with congenital heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

2 October 2017

Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

11 July 2018

Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Effects of long-term bosentan in children with pulmonary arterial hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Safety and tolerability of bosentan in adults with Eisenmenger physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Initial experience with bosentan therapy in patients with the Eisenmenger syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

24 September 2018

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955562

14 November 2018

Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary Arterial Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17135220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.2006.097360

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35956167&oldid=1522425883"